Noninflammatory monocyte macrophages use ␣ v ␤ 3 integrin to selectively bind apoptotic cells, initiating their phagocytic removal. In a related process, the retinal pigment epithelium (RPE) employs ␣ v ␤ 5 integrin to recognize spent photoreceptor outer segment particles (OS). Here, we show that apoptotic cells and OS compete for binding to these receptors, indicating that OS and apoptotic cells expose surface signals recognizable by ␣ v ␤ 3 and ␣ v ␤ 5. Particle binding to ␣ v ␤ 5 required protein kinase C (PKC) activation. In RPE, ␣ v ␤ 5 binding was maximally activated even before any phagocytic challenge and was reduced by PKC inhibitors. In macrophages, it was dormant but became activated upon PKC stimulation. PKC-activated ␣ v ␤ 5-mediated binding in macrophages differed from constitutive binding to the same integrin receptor in RPE cells in that the former followed much faster kinetics, similar to particle binding mediated by ␣ v ␤ 3. Activation of ␣ v ␤ 5 for particle binding correlated with its recruitment into a detergent-insoluble fraction, a process sensitive to pharmacological modulation of PKC in both types of phagocytes. Furthermore, ␣ v ␤ 5 but not ␣ v ␤ 3 particle binding required actin microfilaments. These data constitute the first evidence that noninflammatory phagocytes actively regulate the earliest phase of phagocytic clearance, particle binding, by controlling receptor activity.
C learance phagocytosis of apoptotic cells and debris plays a critical role in remodeling and maintenance of tissues. Noninflammatory phagocytosis prevents tissue damage that would result from leakage of cytoplasmic components (1, 2) . Typical examples of this macrophage activity are the efficient removal of large numbers of apoptotic cells during embryonic development (3) or of activated granulocytes undergoing programmed cell death at the end of an immune response (4) . The binding and phagocytosis phases of apoptotic cell removal each involve specific receptors in the macrophage, such as the lipopolysaccharide receptor CD14 (5) , phosphatidylserine receptors (6), the integrin receptor ␣ v ␤ 3 (7) , and the scavenger receptors SRA1 and CD36 (8, 9) . Binding receptors recognize phosphatidylserine, oxidized lipids, and other unidentified phagocytic signals exposed by apoptotic cells (10, 11) . The available data suggest that different recognition receptors initiating phagocytosis of apoptotic cells may be used independently, depending on the activation state of the macrophage population (12, 13) . This is especially well established for the availability of ␣ v ␤ 3 integrin for apoptotic cell binding. ␣ v ␤ 3 does not participate in particle binding by macrophages that were previously stimulated by thioglycollate, activated by cytokines, or phagocytically challenged (12, 14) . In contrast, ␣ v ␤ 3 is an important binding receptor in noninflammatory bone marrow-or monocyte-derived macrophages, as ␣ v ␤ 3 function-blocking antibodies or peptides containing the cognate integrin ligand motif Arg-Gly-Asp drastically reduce particle attachment (7, 12) . Monocyte-derived macrophages use either ␣ v ␤ 3 integrin or leukocyte-specific integrin receptors ␣ M ␤ 2 (CD11b/CD18, CR3) and ␣ X ␤ 2 (CD11c/CD18, CR4), presumably in parallel, to bind apoptotic cells, which have been opsonized with complement components (15) . The mechanisms used by macrophages to activate or deactivate specific binding receptors for apoptotic cells are entirely unknown.
Noninflammatory receptor-mediated clearance of cell Phagocyte Regulation of Integrin ␣ v ␤ 5 for Apoptotic Cell Binding debris is also efficiently carried out by a specialized tissue in the retina, the retinal pigment epithelium (RPE). 1 RPE cells phagocytose huge loads of material shed by the adjacent photoreceptor layer ( ‫ف‬ 7% of their outer segment mass, daily) as part of a circadian renewal program that compensates the damaging effects of light (16, 17) . RPE phagocytosis of shed outer segment particles (OS) is key for the integrity of the eye, as its failure leads to retinal degeneration (18, 19) . RPE cells highly prefer OS over bacteria, yeast, and opsonized red blood cells, even when they may express a population of Fc receptors (20) . CD36 is expressed by the RPE and participates in the internalization phase of OS clearance (21) . Indirect evidence suggests that a mannose receptor-like activity also plays a role in RPE internalization of OS (22) . However, the RPE mannose receptor sequence has not yet been cloned, and its exact role in OS phagocytosis is unclear. Although only some soluble mannose receptor ligands affect OS phagocytosis (23, 24) , yeast and zymosan particles, which are recognized by macrophages via the mannose receptor, do not compete with OS for binding or internalization by RPE cells (20, and our unpublished results). OS binding by RPE cells and apoptotic cell binding by macrophages use the related integrin receptors ␣ v ␤ 5 and ␣ v ␤ 3, respectively (25, 26) . However, the binding phases of the two processes show some important differences: (a) RPE cells bind OS slowly (over ‫ف‬ 2 h) only after a lag phase (20, 26) , whereas macrophages bind particles maximally in 30 min. (b) RPE cells bind OS only at temperatures Ͼ 17 Њ C (27) , whereas a temperature requirement of macrophage binding of apoptotic cells, to our knowledge, has not been reported. However, macrophage binding of particles via Fc receptors or complement receptor ␤ 2 integrins is normal at 0 Њ C (28) . (c) RPE cells primarily use ␣ v ␤ 5 (25, 26) for particle binding ( ␣ v ␤ 5 antibodies reduce binding by 85%), whereas macrophages may use ␣ v ␤ 3 and other receptors, in parallel ( ␣ v ␤ 3 antibodies reduce binding by ‫ف‬ 50%). Very recent work has shown that phagocytosis of apoptotic cells by immature human blood-derived dendritic cells can be reduced to a similar extent by ␣ v ␤ 5 integrin-inhibiting antibodies; upon cytokine-induced maturation, the phagocytic activity of these cells decreases coincident with downregulation of ␤ 5 (29) .
The experiments in this report characterize the role of ␣ v ␤ 3 and ␣ v ␤ 5 integrin receptors in the initial binding phase of monocyte macrophage and RPE phagocytosis of apoptotic cells and OS. We first tested the hypothesis that the specific particle ligand (OS versus apoptotic cell) could determine the use of a particular integrin, ␣ v ␤ 5 by RPE and ␣ v ␤ 3 by macrophages. The experiments led us to discard this hypothesis as both cell types recognized apoptotic cells and OS efficiently and competitively, employing the same binding integrins they use for their respective physiologic ligands. As both phagocyte types expressed ␣ v ␤ 3 and ␣ v ␤ 5, we tested the hypothesis that the activation of a particular integrin pathway by each cell type could be regulated by specific signaling pathways. Indeed, this was observed: our experiments revealed a critical role for PKC in activating ␣ v ␤ 5 for particle binding. Activation of dormant ␣ v ␤ 5 receptors in macrophages did not alter cell-specific differences in particle binding, as these receptors bound apoptotic cells or OS with fast kinetics distinct from the characteristic slow onset of binding initiating RPE phagocytosis. Both ␣ v ␤ 5 and ␣ v ␤ 3 integrins required temperatures of at least 18 Њ C for particle binding, in contrast to ␤ 2 integrins or Fc receptors. Remarkably, ␣ v ␤ 5 receptors themselves became resistant to detergent extraction upon PKC activation. Since intact actin microfilaments were required for ␣ v ␤ 5-mediated particle binding, interaction with the actin cytoskeleton appears to be an important feature of ␣ v ␤ 5 receptor activation.
Materials and Methods
Materials. Reagents were from Sigma Chemical Co. or GIBCO BRL unless otherwise stated. Pharmacological reagents were obtained from Biomol or Sigma Chemical Co., stored as 1,000 ϫ stock solutions in DMSO at Ϫ 20 Њ C, and diluted into cell culture medium directly before use. The following antibodies were used: rat ␣ v ␤ 3 function-blocking ␤ 3 antibody clone F11 (30, 31) and mouse ␤3 function-blocking antibody clone 2C9.G2 (32) were from PharMingen. Immunoprecipitating, function-blocking, heterodimer-selective ␣v␤5 antibody clone P1F6 (33) was from Chemicon. P1F6 recognizes ␣v␤5 in many species, including rodents (26, 33 ; and this study, see Fig. 8 ). For immunoblot detection, ␤5 antibodies were purchased from Chemicon or from Upstate Biotechnology (clone B5-IVF2 [34] ), and ␤3 antibody clone 26 was from Transduction Laboratories. Myeloperoxidase antiserum was from Dako. Mouse ␣M function-blocking antibody 5C6 (35) was a gift from Dr. W.A. Muller (Weill Medical College of Cornell University). Secondary antibodies were from Jackson ImmunoResearch Laboratories.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) detection was performed using the Fluorescein In Situ Cell Death detection kit from Boehringer Mannheim. Surface phosphatidylserine was detected using the ApoAlert Cell Death detection kit from Clontech.
Cell Culture. J774.A1 murine macrophages, NRK-F49 rat fibroblasts, and rat RPE-J cells were obtained from American Type Culture Collection and routinely maintained in DMEM supplemented with 10 or 4% (RPE) FCS. For binding and phagocytosis experiments, macrophages and fibroblasts were seeded at confluence on glass coverslips for 30 min or overnight before use. RPE-J cells were differentiated on semipermeable filters as described previously (36) . Rat primary cells were isolated from adult Long Evans rats (Richard Harlan, Inc.) immediately after CO 2 asphyxiation. Rat bone marrow-derived macrophages and rat blood-derived monocyte macrophages were prepared and maintained according to published procedures (13, 37) . In brief, blood-derived monocytes were isolated by plastic adherence after Ficoll gradient purification of leukocytes from anticoagulanttreated rat blood. Bone marrow cells were flushed aseptically from femur bones of Long Evans rats, washed, seeded, and used without repassaging. All primary macrophages were cultured for
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Finnemann and Rodriguez-Boulan 6-7 d before use in IMDM, supplemented with 10% autologous serum; bone marrow-derived cell medium was supplemented with 5% L cell-conditioned medium (Sigma Chemical Co.) as a source of M-CSF (13) . Primary rat neutrophils, which were isolated from fresh rat blood according to established protocols (38) , underwent spontaneous apoptosis over 24 h in culture. HL-60 cells, a gift from Dr. F. Maxfield (Weill Medical College of Cornell University) were maintained in 10% FCS in RPMI. To induce differentiation and apoptosis, HL-60 cells were cultured in the dark at 2 ϫ 10 5 cells/ml in growth medium containing 1 M all-trans retinoic acid for 6 d. Before binding or phagocytosis assays, apoptotic cells were routinely tested for viability by trypan blue exclusion and phosphatidylserine surface exposure staining with FITC-annexin V. All populations used were Ͼ95% viable and Ͼ60% annexin V positive.
Preparation of Photoreceptor OS. OS were isolated according to established protocols from bovine eyes obtained fresh from the slaughterhouse (39) . OS were stored suspended in 10 mM sodium phosphate, pH 7.2, 0.1 M sodium chloride, 2.5% sucrose at Ϫ80ЊC. Before use, OS were thawed and labeled by addition of 20% vol of 1 mg/ml FITC or 0.2 mg/ml Texas red (both from Molecular Probes) in 0.1 M sodium bicarbonate, pH 9.0, for 1 h at room temperature in the dark, before being washed and resuspended in cell culture medium.
Opsonization of Zymosan. Zymosan particles were opsonized with serum complement components as described previously (40) . In brief, 1% zymosan particles in PBS were boiled for 30 min and opsonized in 50% bovine serum in HBSS for 1 h at 37ЊC. Washed particles were labeled with FITC as described for OS, and stored at 4ЊC.
Particle Binding and Phagocytosis Experiments. To study particle binding, phagocytes at confluence were challenged with 10 particles per cell in growth medium (RPE) or serum-free growth medium (other cells) for the duration of the experiment, washed three times with PBS containing 1 mM MgCl 2 and 0.2 mM CaCl 2 (PBS-CM), and fixed in ice-cold methanol. OS were covalently labeled with FITC or Texas red, and thus could be observed directly. Apoptotic cells were visualized by TUNEL staining or by granulocyte-specific myeloperoxidase immunofluorescence staining using FITC-or Texas red-conjugated secondary antibodies. Nuclei were counterstained with DAPI or propidium iodide at 1 ng/ml in PBS-CM. For competition experiments, OS and apoptotic cells were labeled with different fluorochromes. Particle labeling with either fluorochrome yielded identical results. Unlabeled particles competed with fluorescence-labeled particles for binding and phagocytosis by all cell types. For inhibition experiments, GRGDSP or GRADSP peptides (Calbiochem) were used at 1 mg/ml. Effects of peptides and antibodies were concentration dependent as established previously (26) , and maximal effective concentrations of antibodies, 20-50 g/ml, were used throughout this study. Concentrations of pharmacological reagents were as follows: calphostin C at 100 nM (light activated), cytochalasin D (Cyt D) at 5-20 M, Gö6976 at 10 nM, hypericin at 5 M, and latrunculin B at 1 M. PMA was routinely used at 50 nM; 16-160 nM gave similar results. Cells were pretreated for times indicated in the figure legends with activators or inhibitors before challenge with OS or apoptotic granulocytes in the continuous presence of reagent. Cell viability and morphology remained unchanged, and none of the cell types initiated detectable apoptosis over the course of the experiments. Since experiments were performed on confluent cells, the spreading effect of PMA on macrophages was negligible.
Phagocytosis or binding of OS was quantified by fluorescence scanning of fixed samples as described (26) . Samples were scanned with a STORM 860 Imager, at 950 V (blue or red fluorescence setup; Molecular Dynamics). Areas representing the binding by 1-2 ϫ 10 5 phagocytes were selected, and the fluorescent signals were quantified with ImageQuant 1.2 (Molecular Dynamics). Within one experiment, particle counts directly correlated with particle binding. To compare particle binding of different cell types, as RPE cells and macrophages, the fluorescence of propidium iodide (nuclei, red) and the particle-derived FITC fluorescence were both measured in each field. The binding plus internalization index or the binding index (bound particles at early times of phagocytic challenge) were calculated dividing particle counts by nuclei counts, thereby normalizing for phagocyte numbers. Quenching of fluorescence derived from externally bound particles using trypan blue (26, 41) allowed determination of the internalization index. Phagocytosis or binding of apoptotic cells was quantified following the same procedure based on TUNEL or myeloperoxidase immunostaining fluorescence emissions; binding indices were determined dividing by nuclei counts of control fields, so as not to count apoptotic nuclei. Microscopic observation revealed that 75% of RPE-J cells and Ͼ90% of J774 cells had bound or phagocytosed an average of 5 Ϯ 1 OS after 2 h. Using the double fluorescence scanning method on the same samples, this translated into a mean index combining binding plus internalization of 7.6 Ϯ 0.9 for macrophages and 6.3 Ϯ 0.9 for RPE. After 30 min, 75% of macrophages had bound multiple OS; this translated to a mean binding index of 3.8 Ϯ 0.4. At this time point, Ͻ20% of particles had been internalized by macrophages, similar to the 2-h time point of RPE (26, 41) .
Immunofluorescence Microscopy. Samples were fixed in ice-cold methanol or 4% paraformaldehyde in PBS-CM and processed as described previously (42) . Samples were observed with a Nikon fluorescence microscope E600. Digital images were acquired with a back-illuminated cooled CCD camera (CCD1000 PB; Princeton Instruments), translated using MetaMorph (Universal Imaging), and recompiled in Adobe Photoshop ® 4.0. Horizontal (x-y) sections were acquired at 0.5-m steps using a z motor (Prior), and out of focus light was removed using MetaMorph.
Cell Fractionation. Integrin cytoskeletal association was assayed by cell fractionation into detergent-soluble and insoluble fractions according to previously described protocols (43) . Confluent cells in 6-cm dishes, preincubated with pharmacological reagents or vehicle as before binding or phagocytosis assays, were extracted in 800 l 50 mM MES, 5 mM MgCl 2 , 3 mM EGTA, 0.5% Triton X-100, pH 6.4, for 40 s at room temperature (soluble fraction). The remaining cellular material was completely solubilized in an equal volume of RIPA (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 0.1% SDS, 1% sodium desoxicholate, 1% Triton X-100) (insoluble fraction). Equal volumes of soluble and insoluble fractions were compared by 7.5% SDS-PAGE and immunoblotting. For immunoprecipitation of integrins from the different fractions, the soluble fraction was harvested as described above, whereas the insoluble fraction was obtained by scraping the remaining cellular material in an equal volume of 50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1% Triton X-100, 1% NP-40 supplemented with 2 mM each of aprotinin, leupeptin, pepstatin, iodoacetamide, and PMSF, and 1 mM N-ethylmaleimide (IP lysis buffer), vortexing for 30 min at 4ЊC. This procedure completely solubilized integrin proteins. Immunoprecipitations were performed from this insoluble and the soluble fraction as follows.
Surface Protein and Immunoprecipitations, SDS-PAGE, and Immunoblotting. For metabolic labeling, confluent cells on plastic 864
Phagocyte Regulation of Integrin ␣v␤5 for Apoptotic Cell Binding dishes were starved for 90 min in cysteine, methionine-free DMEM, and labeled with 0.1 mCi/ml 35 S Express (NEN) for 12-14 h. Preincubation with pharmacological reagents or vehicle as control was performed as before binding/phagocytosis assays. To biotinylate surface proteins, cells were incubated with Sulfo-NHS-LC biotin (Pierce Chemical Co.) at 0.5 mg/ml in PBS-CM twice for 20 min on ice. Excess reactive biotin was quenched in 50 mM NH 4 Cl in PBS-CM. Cells were lysed in IP lysis buffer for 30 min. Protein concentration of supernatant lysates was determined according to Bradford (44) . Crude lysates were analyzed by nonreducing 7.5% SDS-PAGE followed by Western blot detection of integrins as published previously (45) . Streptavidin-agarose precipitation has been described in detail elsewhere (46) . Immunoprecipitates were formed incubating precleared lysate with 5 g P1F6 IgG or nonimmune mouse IgG, with 5 g rabbit anti-mouse IgG, and with 5 mg protein A-sepharose, each for 1 h at 4ЊC. Samples were washed four times in 50 mM Tris-HCl, pH 8.5, 0.5 M NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1 mg/ml egg albumin, 0.1% Triton X-100 eluted in nonreducing or reducing SDS sample buffer, and analyzed on 10% SDS-PAGE followed by fluorography or blotting. Blots were incubated with integrin antibodies, horseradish peroxidaseconjugated streptavidin, or secondary antibodies, followed by ECL (NEN) detection. X-ray films were scanned, and signals were quantified using NIH Image 1.61.
Results

Macrophages and RPE Cells Bind, Nonpreferentially, OS and Apoptotic Cells but Use Different Integrins for This Purpose.
Blood monocyte or bone marrow-derived macrophages use ␣v␤3 integrin receptors to bind apoptotic cells before phagocytosis (7), whereas RPE cells bind OS via ␣v␤5 integrins (25, 26) . We initially tested the hypothesis that the characteristic choice of different integrin receptors by macrophages and RPE cells was determined by differences in the bound particles. To this end, we exposed the phagocytes to the physiologic ligands of the other cell, i.e., macrophages to OS and RPE cells to apoptotic cells (Fig. 1) . Rat bone marrow macrophages and the murine macrophage cell line J774, which retains the ␣v␤3 integrin-dependent apoptotic cell clearance mechanism of noninflammatory monocyte macrophages (13) , efficiently bound and phagocytosed OS (Fig. 1, a and b) . Primary cultures of rat RPE, and rat (RPE-J) and human (ARPE-19) RPE cell lines identified and took up apoptotic granulocytes (and other apoptotic cells; data not shown), but not their nonapoptotic counterparts (Fig. 1, c-f ). Most subsequent studies were performed on J774 macrophages and RPE-J cells, but were confirmed on rat bone marrow-derived macrophages and primary rat RPE cultures.
Particle binding and phagocytosis proceeded with kinetics that were characteristic for each cell type. Macrophages bound and internalized OS with the same rapid and linear kinetics with which they take up apoptotic cells (Fig. 2 a, and data not shown). The early phase of RPE clearance of OS is characterized by a lag phase following particle challenge after which OS binding occurs rapidly (26) . RPE cells bound apoptotic cells as slowly as OS (Fig. 2 a) . After 2 h of phagocytic challenge, the sum of bound plus internalized OS was similar in macrophages and RPE cells (Fig.  2 a) . However, at this time 78 Ϯ 9% of these OS in macrophages had been internalized, compared with only 17 Ϯ 4% internalized OS in RPE cells. Phagocytosis of apoptotic cells bound by RPE cells followed the same slow time course as previously established for OS: we removed unbound apoptotic cells after 2 h and followed the fate of bound cells. Over the next 3 h, 85% of bound apoptotic cells were internalized by RPE cells (26; and data not shown).
To specifically address particle binding, we chose to study 30 min of particle challenge for macrophages and 2 h for RPE cells, both of which corresponded primarily to the recognition/binding phase of particle clearance (see above, and Materials and Methods). Peptides containing the cognate integrin-binding motif, RGD, reduced binding of both particles by either phagocyte (Fig. 2 b) . In contrast, function-blocking ␤3 antibodies only inhibited particle binding by macrophages while ␣v␤5 antibody P1F6 only blocked RPE recognition (Fig. 2 b) . OS and apoptotic cells competed for binding by both macrophages and RPE cells (Fig. 2 c) . These experiments indicate that neither macrophage nor RPE binding receptor systems discriminate between ligands of both particles and that these systems involve ␣v␤3 in macrophages and ␣v␤5 in RPE cells.
Binding of Apoptotic Cells and OS by ␣v␤5 Is Dormant in Macrophages but May Be
Activated by PKC. We tested three hypotheses that might account for particle binding by different integrin binding receptors in macrophages and RPE cells. Hypothesis 1 was that cell type-specific integrin protein expression determined receptor availability for particle binding. However, Fig. 3 shows that selective integrin expression was not involved, as both ␤3 and ␤5 were expressed at similar levels by J774 cells, rat bone marrowderived macrophages, and RPE-J cells. Immunoprecipitation of ␣v␤5 from RPE and macrophage lysate using the antibody P1F6, which recognizes only intact heterodimers, and coimmunoprecipitation of ␤3 integrin with ␣v integrin confirmed the formation of ␣v␤3 (data not shown) and ␣v␤5 receptors (see Fig. 8 ). We have shown previously that the steady state distribution of ␤3 integrins is basolateral in the RPE (26) . Although this does not exclude a temporary presence of ␣v␤3 at the apical phagocytic surface, this spatial segregation may render it less available for efficient apoptotic cell or OS binding by the RPE than ␣v␤5, which localizes apically and cytoplasmically. In contrast, double immunofluorescence staining with antibodies recognizing the ␤3 extracellular domain and with P1F6 antibodies specific for the extracellular face of the ␣v␤5 receptor complex showed that in nonpermeabilized macrophages, both antigens were localized in the same optical sections of the plasma membrane of a given cell, even if their distribution within the plane of the membrane differed. Like ␤3 integrins, ␣v␤5 receptors localized partially to basal attachment sites of macrophages but were also available at their free surface for binding to apoptotic cells or OS.
Hypothesis 2, applicable to macrophages, was that their preferred use of ␣v␤3 for apoptotic cell or OS binding might be based on the faster early kinetics of this pathway over ␣v␤5-mediated uptake (Fig. 2 a) . To facilitate detec- Figure 3 . J774 and rat macrophages express similar levels of ␣v, ␤3, and ␤5 integrin subunits as rat RPE-J cells and rat NRK-F49 fibroblasts. Proteins were detected by comparative immunoblotting after SDS-PAGE of 50 g each of detergent lysates of RPE-J cells, J774 macrophages, primary rat monocytes (Mono), and rat NRK-F49 fibroblasts. Tested rodent primary macrophages and cell lines expressed levels of ␤5 integrin protein comparable to RPE cells, while an earlier study did not detect ␤5 in human monocyte-derived macrophages (reference 29). This may be attributed to species differences, or to differences in in vitro monocyte maturation conditions. tion of a hidden ␣v␤5 particle binding activity, ␣v␤3 receptors were depleted from the free macrophage surface. When compared with control cells plated on laminin (which is not a substrate for either ␣v␤3 or ␣v␤5), a large fraction of ␣v␤3 receptors was recruited to the attached surface in macrophages plated on the specific ␣v␤3 substrate fibrinogen (47; compare Fig. 4 , a1 and a2, with Fig.  4, b1 and b2 ), resulting in a reduction in particle binding of 40% after 30 min of particle challenge (Fig. 5 a) , and a 44% decrease of combined binding and internalization even after 90 min (Fig. 5 b) . ␣v␤5 receptor distribution remained unchanged on fibrinogen, as judged from the similar appearance of ␣v␤5 immunofluorescence signals on both attached and open cell surfaces on laminin and fibrinogen (compare Fig. 4 , a3 and a4, with Fig. 4, b3 and b4) . However, the remaining binding at 30 min and the combined binding plus internalization at 90 min were still reduced by ␤3 but not by ␣v␤5 function-blocking antibodies (Fig. 5) . Incubation with ␤3 antibody in the presence of the peptide inhibitor GRGDSP did not have an additive effect (but the peptide alone reduced binding by ‫;%03ف‬ data not shown, and see Fig. 2 b) , indicating that ␣v␤3 was the only RGDsensitive receptor, which mediates apoptotic cell or OS recognition in this system. However, ligand binding by leukocyte ␤2 integrins may not be inhibitable by RGD peptides (48) . At the 90-min time point, at least 65% of the particles had been internalized (Fig. 5 b, black bars) . Comparing total and internal particles of laminin-and fibrinogen-seeded macrophages, differences in internalized particles were less pronounced than differences in surface-bound particles (as deduced by subtracting internal from total particles), confirming that attachment to fibrinogen inhibited particle binding but not internalization (Fig. 5 b, gray and black bars). Similar results were obtained when cells were plated on ␤3 integrin antibodies or on vitronectin, a substrate for both ␣v␤3 and ␣v␤5 (Fig. 5) . These experiments indicate that ␣v␤5 integrin receptors are present in macrophages but are not active in apoptotic cell or OS binding.
Hypothesis 3 was that integrin-mediated binding of apoptotic cells or OS was subject to cell type-specific regulation. Several earlier studies have reported that, unlike ␣v␤3 integrin, ␣v␤5 is sensitive to pharmacological modulation by protein kinase C (PKC) (33, 49, 50) . Here, we compared the effects on macrophage and RPE particle binding of generic PKC activation using phorbol esters (PMA), and inhibition by calphostin C, Gö6976, and hypericin. Inhibitors were used at concentrations near IC 50 for PKC. PMA treatment did not alter RPE particle binding; on the other hand, calphostin C, Gö6976, and hypericin reduced binding by RPE cells (Fig. 6 a) . Significant inhibition (by 54%) by calphostin C required a preincubation of 3 h. It is possible that RPE cells take up calphostin C more slowly than other cultured cells or maintain lower cytoplasmic concentrations of this inhibitor. Hypericin and Gö6976 significantly reduced particle binding after as little as 30 min of preincubation by 39 and 22%, respectively, but both were also more effective after 3 h of preincubation (69 and 81% reduction). These experiments indicate that the apoptotic cell or OS binding activity of resting confluent RPE cells is drastically reduced by pharmacological inhibition of PKC.
A strikingly different scenario was observed in the case of macrophages. PKC inhibition by calphostin C, Gö6976, or hypericin did not alter particle binding, regardless of preincubation time. On the other hand, stimulation of PKC by incubation with PMA increased particle attachment by 45%. This enhanced binding activity was sensitive to RGD-containing peptides, to ␤3 antibodies, and, importantly, to ␣v␤5 antibody Fab fragments (Fig. 6 b) . Thus, PMA treatment activated ␣v␤5-mediated particle binding that was dormant in untreated macrophages. The effect of the PMA treatment directly involved PKC, since it was abolished by preincubation of cells with calphostin C for 20 (n ϭ 3) . Note that cells seeded for 30 min before particle challenge, as studied in this experiment, bound fewer particles than cells which had attached overnight (see Fig. 2 ). Results represent data from OS challenges. Identical results were obtained challenging with apoptotic cells. Cell adhesion or morphology did not notably change due to attachment to the ␤3 antibody or to different substrates (LN, laminin; Fb, fibrinogen; VN, vitronectin). Attachment to ␣v␤5 or ␤1 antibody had no effect on particle binding (data not shown). min before PMA and particle challenge. To confirm the PKC dependence of ␣v␤5-mediated apoptotic cell or OS binding in a different cell context, we carried out similar experiments in NRK-F49 fibroblasts. When challenged with OS for 2 h, these cells bind (but do not internalize) few OS, equivalent to one fifth of the number bound by RPE over the same period (Fig. 2 a) , although they express comparable levels of ␣v, ␤3, and ␤5 integrins (Fig. 3) . Incubation with integrin antibodies had no effect on the basal NRK-F49 particle binding of apoptotic cells or OS (data not shown). However, addition of PMA stimulated particle binding by NRK-F49 fibroblasts by 250% to a binding index of 3.4 Ϯ 0.5, which is an increase to approximately half-maximal binding capacity of professional phagocytes. Strikingly, this induced binding activity was completely sensitive to RGD peptides, was blocked specifically by ␣v␤5 antibodies, and was not sensitive to ␤3 antibodies (Fig. 6 c) . Over the 2-h time period studied, NRK-F49 fibroblasts retained particles at the surface and did not internalize them, regardless of pharmacological stimulation. These experiments demonstrate that inhibition and activation of PKC regulate the function of ␣v␤5 integrin as binding receptor for apoptotic cells or OS.
To determine if the stimulated ␣v␤5 integrin-mediated particle binding in macrophages exhibited typical features of OS binding by RPE cells, we compared the temperature sensitivity and kinetics of particle binding and internalization by J774 cells, in the presence or absence of PMA. Total (bound plus internalized) and internalized particles were measured to calculate binding and internalization indices plotted in Fig. 7 . Onset of binding of apoptotic cells or OS to control and PMA-stimulated cells occurred with the same rapid kinetics typical of macrophages (Fig. 7 a, solid  lines) . When challenged with particles for 30 min or longer, both control and PMA-stimulated cells increasingly internalized bound material (Fig. 7 a, dotted lines) , resulting in a decrease in particles detected bound to the cell surface. J774 cells, which were equilibrated to 18ЊC before particle challenge, also bound both particles with the same fast kinetics regardless of whether they had been preincubated with PMA or with solvent alone, albeit slightly delayed regarding the 37ЊC time course (Fig. 7 b, solid lines) . Under these conditions, Ͻ10% of total particles were internalized regardless of PMA treatment and time of incubation (Fig. 7 b, dotted lines) . Finally, incubation at 14ЊC or on ice during particle challenge abolished particle binding with or without PMA treatment (Fig. 7, c and d) , while allowing normal binding of complement-opsonized zymosan via macrophage ␣M␤2, sensitive to ␣M-blocking antibody 5C6 (data not shown). These experiments demonstrate that apoptotic cell or OS binding by macrophages via ␣v␤3 or ␣v␤3 plus ␣v␤5 integrin shows the same temperature requirement as particle binding via ␣v␤5 to RPE cells. On the other hand, PMA-stimulated macrophages, which possess an activated ␣v␤5 integrin, bind apoptotic cells or OS with the same rapid kinetics as control macrophages, which do not use ␣v␤5, indicating that RPE particle binding does not occur slowly due to an intrinsic property of ␣v␤5. Results are expressed as means Ϯ SEM, of six independent experiments performed in duplicate. Using the Student's t test, P Ͻ 0.001 for all conditions discussed as significant in the text. (a) Effects of PKC activators and inhibitors on RPE-J particle binding. Longer preincubation time increased the effects of all PKC inhibitors used, suggesting that immediately before particle addition, RPE ␣v␤5 is already activated. Mean binding index of controls (100%) after 2 h of particle challenge was 5.39 Ϯ 0.9 regardless of preincubation time. (b) Effect of PKC activators and inhibitors on macrophage particle binding. J774 or rat primary macrophages were preincubated for 30 min or 3 h in growth medium with pharmacological reagents or solvent, before OS challenge for 30 min. Similar results were obtained incubating with apoptotic cells, which competed with OS for binding to PMA-activated macrophages (data not shown). Binding index of controls (100%) was 4.2 Ϯ 0.7. (c) Activation of ␣v␤5-mediated particle binding in NRK-F49 fibroblasts induced by PMA treatment. Cells were preincubated with reagents for 30 min before challenge with OS for 2 h, at which time point numbers of internalized apoptotic cells or OS were insignificant. Mean binding index of control fibroblasts was 1.36 Ϯ 0.2, and of PMA-treated cells was 3.4 Ϯ 0.5.
PKC-activated ␣v␤5 Is Linked to the Actin Cytoskeleton.
To gain insight into the mechanism of activation of ␣v␤5-mediated binding of apoptotic cells or OS by PKC, we searched for biochemical changes associated with PKC activation. Pharmacological activation or inhibition of PKC did not influence ␣v␤5 receptor levels in either cell type (Fig. 8 a, compare lane 2 with lane 3, and lane 5 with lane 6) or their steady state expression levels at the cell surface, as revealed by surface biotinylation, ␣v␤5 immunoprecipitation, and streptavidin blot (Fig. 8 b, lanes 1-6) or enrichment of plasma membrane fractions and ␤5 immunoblot (Fig. 8 b, lanes 7-12) . Incomplete extraction of plasma membrane proteins with 0.5% Triton X-100 in a buffer that preserves the cortical cytoskeleton serves to distinguish integrin receptors, which are stabilized by actin cytoskeletal elements (43, 51) . PKC inhibition in RPE and PKC activation in macrophages correlated with decreased and increased ␤5 resistance to nonionic detergent, respectively, as shown in Fig. 9 , a and b, suggesting a regulation of ␤5 association with actin cytoskeletal elements. ␤5 was 65% insoluble in control RPE, 58% insoluble in PMA-treated RPE, but only 33% insoluble in RPE treated with PKC inhibitor Gö6976. In contrast, ␤5 was mostly soluble in control macrophages (5% insoluble) but became 78% insoluble after PMA incubation. This effect was greatly inhibited in the presence of Gö6976 (23% insoluble). This effect was specific for ␤5, as ␤3 solubility was unaffected by PKC activation/inhibition (Fig. 9, a and b, lower lanes) . ␤3 integrin was 30% insoluble in RPE and 40% insoluble in J774 cells, regardless of treatment. Pretreatment of RPE or macrophages with the actin microfilament disrupting drug, Cyt D, rendered ␤3 and ␤5 completely soluble in RPE and macrophages, confirming that integrin resistance to nonionic detergent extraction in our biochemical analysis reflected their association with actin microfilaments (Fig. 9, a  and b, lanes 7 and 8) . As expected, PMA treatment did not induce integrin insolubility in cells in which actin microfilaments had been disrupted by Cyt D (Fig. 9, a and b, lanes  9 and 10) . We further determined the detergent solubility of intact ␣v␤5 receptors (Fig. 9 c) . Strikingly, the effect of PKC activation or inhibition on ␣v␤5 heterodimer solubility was most pronounced: 90% of ␣v␤5 in RPE cells was insoluble but became mostly solubilized (26% insoluble) upon incubation with the PKC inhibitor Gö6976 (Fig. 9 c,  lanes 1-6) . In control macrophages, the entire ␣v␤5 receptor pool was present in the soluble fraction (Fig. 9 c, lanes 8  and 10) . In contrast, PMA-treated macrophages exhibited 62% insoluble ␣v␤5 (Fig. 9 c, lanes 11 and 12) . Attempts to visualize the change in receptor solubility by indirect immunofluorescence staining of ␣v␤5 or ␤5 in cells fixed before or after a short pulse of nonionic detergent failed, as, unfortunately, detergent pretreatment abolished all immunoreactivity. Loss of immunoreactivity after detergent treatment was independent of cell type or pharmacological treatment, suggesting that antibody-antigen binding did not tolerate detergent treatment followed by paraformaldehyde fixation. Nonetheless, the biochemical changes observed clearly demonstrate that ␣v␤5 function as particle binding receptor correlates with its increased resistance to nonionic detergent extraction, which was reversibly regulated by PKC signaling.
To directly test the possibility that an intact actin cytoskeleton might be required for ␣v␤5-mediated particle binding, we challenged J774 macrophages with OS in the presence or absence of PMA and Cyt D. Fig. 10 shows particle binding determined at 18ЊC to minimize phagocytosis of bound particles. OS bound efficiently to control macrophages even in the presence of Cyt D (Fig. 10) , in both cases in an ␤3 integrin-sensitive, ␣v␤5-independent manner (average ␤3 antibody inhibition 59% in control cells, 42% in Cyt D-treated cells). Increased OS binding in the presence of PMA exhibited the dual ␤3-and ␣v␤5-dependent mechanism (51% inhibited by ␤3 antibody, 39% inhibited by ␣v␤5 antibody), and blocking of both integrins with a combination of antibodies resulted in maximal inhibition of OS binding (75%). Strikingly, the addition of Cyt D decreased OS binding to PMA-treated cells by 40%, abolishing the increase induced by PMA. Addition of ␣v␤5-inhibiting antibody to these cells had no effect, whereas OS binding remained sensitive to ␤3-inhibiting antibodies (52% inhibition). Similar effects on PMA-induced particle Figure 8 . PKC activation or inhibition does not alter levels or plasma membrane localization of ␣v␤5 receptors. RPE-J cells were pretreated with solvent (Ϫ) or PMA for 30 min (P) or with Gö6976 for 3 h (G) before lysis. J774 cells were pretreated with solvent (Ϫ), PMA (P), or Gö6976 for 30 min (G), and lysed. (a) ␣v␤5 heterodimer levels. Immunoprecipitates from total IP lysate with nonimmune mouse IgG (lanes 1, 4, 7, and 9), or with ␣v␤5 antibody P1F6 (other lanes). Lanes 1-6 are fluorographs after immunoprecipitation from radioactively labeled cells and nonreducing SDS-PAGE. Lanes 7-10 are immunoblots after immunoprecipitation from unlabeled RPE-J and J774 lysates detected with ␤5 antibody B5-IVF2 after reducing SDS-PAGE. P1F6 antibody precipitated ␣v␤5 heterodimers from both metabolically labeled RPE-J and J774 cells, and quantification revealed ‫%52ف‬ higher levels in the RPE (compare lane 2 with lane 5; relative intensities RPE 1.0/J774 0.78). Immunoblotting of ␤5 with antibody P1F6 gave similar quantification results and further confirmed the specificity of P1F6 for rodent ␣v␤5. Pharmacological activation or inhibition of PKC did not influence ␣v␤5 receptor levels in either cell type, and intensity differences were not significant. (b) Cell surface localization of ␣v␤5. Cells were pretreated and surface biotinylated before lysis. In lanes 1-6, immune complexes precipitated with P1F6 from biotinylated lysates were probed with streptavidin-peroxidase/ ECL after reducing SDS-PAGE and blotting. Similar steady state levels of surface ␣v␤5 receptors were detected in RPE-J or J774, regardless of PKC inhibition or activation. Note that, under reducing conditions, the ␣v subunit appears at a lower molecular mass than under nonreducing conditions ‫011ف(‬ kD reduced, ‫041ف‬ kD nonreduced). Other bands, possibly coprecipitates, were not identified. Lanes 7-12 show surface protein fractions enriched by streptavidin-agarose precipitation separated by reducing SDS-PAGE. Immunodetection with ␤5 antibody B5-IVF2 confirmed equal amounts of ␤5 protein at plasma membranes of RPE-J cells, regardless of PKC status (lanes 7-9). The same was true for J774 cells (lanes 10-12) . One of three representative experiments is shown for each method. In both types of experiments, minor variations did not correspond to PKC modulation and were insignificant. but not ␤3 resistance to nonionic detergent extraction correlated with PKC activation in RPE and macrophages. Pretreatment conditions were as in Fig. 8 . GϩP represents treatment with Gö6976 for 15 min, followed by the addition of PMA to this inhibitor medium for 30 min. After pretreatment, cells were separated in detergent-soluble and insoluble fractions as described in Materials and Methods. Protein concentrations in the fractions revealed that 35% total cellular protein was present in the soluble fraction, and 65% in the insoluble fraction. This distribution was the same comparing RPE and macrophages and did not change after treatment with PKC activators or inhibitors. Integrin distribution in subcellular fractions were compared by Western blotting with ␤5 polyclonal antibody (upper lanes) or ␤3 antibody 26 (lower lanes) after nonreducing SDS-PAGE. Lanes with odd numbers are soluble fractions (labeled s), and lanes with even numbers are the corresponding insoluble fractions (labeled i), of cell types and treatment as indicated (see legend to Fig. 8 ). Actin microfilament disruption with 10 M Cyt D completely solubilized ␤3 and ␤5 (a and b, lanes 7 and 8) and prevented PMA-induced recruitment of ␤5 into insoluble fractions (a and b, lanes 9 and 10). Shown here is one representative experiment out of a total of five experiments. Corresponding soluble and insoluble fractions were separated in duplicate on the same gels and blotted for ␤5 or ␤3. The appearance of unidentified secondary bands in some ␤5 blots was variable and did not correlate with pharmacological treatment. (c) PKC activation or inhibition regulated extractability of ␣v␤5 heterodimeric receptors. Metabolically labeled cells were pretreated and separated into soluble (lanes 1, 2, 5, 7, 8, and 11, labeled s) and insoluble fractions (lanes 3, 4, 6, 9, 10, and 12, labeled i). From each fraction, immunoprecipitates with nonimmune mouse IgG (lanes 1, 3, 7, and 9) or P1F6 antibody (all other lanes) were analyzed by nonreducing SDS-PAGE and fluorography. Note that J774 immunoprecipitates with P1F6 after separation of cells into soluble and insoluble fractions exhibited lower backgrounds than immunoprecipitates from total cell lysates (see Fig. 8 a, lanes 5 and 6) , possibly due to the dilution of proteins that bound nonspecifically to P1F6 immune complexes. Quantification values given in the text represent means of four experiments, of which one representative experiment is shown.
binding only were observed when 1 M latrunculin B, a different actin-disruptive drug, was substituted for Cyt D (data not shown). When we tested RPE-J particle binding in the presence of 5-20 M Cyt D, we also found their binding activity reduced. However, the morphology of the epithelium was dramatically altered after 2 h of actin disruption. These experiments demonstrate that, in macrophages and RPE-J cells, binding of apoptotic cells or OS to ␣v␤5 integrin receptors but not to ␣v␤3 required intact actin microfilaments.
Discussion
The experiments reported here demonstrate that noninflammatory phagocytosis of apoptotic cells or OS can proceed along routes gated by different integrin-binding receptors, ␣v␤3 and ␣v␤5. Several important aspects of the particle recognition functions of these integrins were unraveled.
Recognition Mechanisms of RPE Cells and Monocyte Macrophages Do Not Distinguish between Surface Signals of Photoreceptor Outer Segments and Signals Exposed during Apoptosis.
Although RPE cells lack inflammatory phagocytic mechanisms mediated in immune cells by Fc receptors, complement receptors, and glycan receptors, they possess a highly efficient clearance pathway for OS. The RPE phagocytic mechanism for OS and apoptotic cells has a capacity similar to the monocyte macrophage phagocytic mechanism. Our results confirm and extend earlier reports that described the extraordinary specificity of the RPE recognition machinery towards OS (20) and of the machinery used by noninflammatory macrophages for apoptotic over normal cells (4) . OS and apoptotic cells quantitatively compete for both monocyte macrophage and RPE binding, demonstrating that the binding receptors used by either cell type to initiate phagocytosis of these types of particles do not discriminate between them. They also suggest that at least some of the local surface changes elicited by the daily photoreceptor outer segment renewal program are functionally equivalent to the recognition signals exposed during apoptosis.
RPE Cells Use ␣v␤5 Integrin, Whereas Macrophages Use ␣v␤3 Integrin to Bind Both OS and Apoptotic Cells. Surprisingly, rat primary and murine J774 macrophages used ␣v␤3 integrin to bind OS, even though they expressed abundant ␣v␤5 integrin at the cell surface. The partial reduction in particle binding observed when using ␣v␤3 inhibitory antibodies and RGD peptides on macrophages confirms earlier reports that they also use nonintegrin binding receptors for apoptotic cells or OS, presumably in parallel mechanisms (for a review, see reference 11). In contrast, RPE cells likely use ␣v␤5 integrin as primary binding receptor for OS, as ␣v␤5-inhibiting antibodies abolish 85% of particle binding. RPE cells bound apoptotic cells as efficiently as OS via an ␣v␤5-dependent pathway, even though they express equal levels of ␤3 integrins as macrophages. Since ␤3 integrins in RPE cells are polarized at the basolateral surface of the RPE, their availability for particle binding may be limited. Although we expect this hypothesis to be difficult to test experimentally in epithelial cells, macrophages do not share similar permeability barriers between plasma membrane domains. Indeed, on appropriate immobilized substrates or specific antibodies, ␤3 integrins were efficiently trapped at macrophage attachment sites, leaving ␣v␤5 receptors exposed at the particle contact surface of the phagocytes. In spite of their favorable exposure, ␣v␤5 receptors failed to mediate apoptotic cell or OS binding. These experiments clearly demonstrate that neither the ligand (OS versus apoptotic cells), the exclusive expression of a given integrin receptor (␣v␤3 versus ␣v␤5), nor its localization at the site of particle contact is sufficient to generate the characteristic receptor selectivity of RPE and macrophage particle recognition.
The Selection of a Particular Integrin Receptor by a Given Phagocyte Is Determined by the Activation of Specific Signaling Pathways. Our results show that specific cellular context determines which integrin receptor, ␣v␤3 or ␣v␤5, will be activated for recognition and binding of OS and apoptotic cells. Pharmacological studies revealed that the PKC signaling pathway plays a key role in the activation of ␣v␤5 for particle binding. Interestingly, RPE cells possess a maximally activated ␣v␤5 integrin-gated binding mechanism Fig. 7 ). Binding by cells treated with DMSO or PMA alone reproduced the integrin inhibition pattern established for 30-min challenge at 37ЊC (see Fig. 6 b) . Both integrins bound particles independently, as dual inhibition had an additive effect on particle binding by PMA-treated macrophages (cross-hatched bars). Cyt D reduced the particle binding index of PMA-activated samples to that of vehicle controls and abolished its sensitivity to ␣v␤5 inhibition. Binding indices are means Ϯ SEM (n ϭ 3) of results obtained with OS. Similar results were obtained challenging macrophages with apoptotic cells.
